Cavicchioni G - Search Results

1

Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity.

Cortesi R, Argnani R, Esposito E, Dalpiaz A, Scatturin A, Bortolotti F, Lufino M, Guerrini R, Cavicchioni G, Incorvaia C, Menegatti E, Manservigi R. Cortesi R, et al. Among authors: cavicchioni g. Int J Pharm. 2006 Jul 6;317(1):90-100. doi: 10.1016/j.ijpharm.2006.02.050. Epub 2006 Apr 5. Int J Pharm. 2006. PMID: 16600535

2

Conformational studies of chemotactic HCO-Met-Leu-Phe-OMe analogues.

Vertuani G, Boggian M, Breveglieri A, Cavicchioni G, Spisani S, Scatturin A. Vertuani G, et al. Among authors: cavicchioni g. Amino Acids. 1995 Dec;9(4):375-83. doi: 10.1007/BF00807274. Amino Acids. 1995. PMID: 24178885

3

Synthesis, biological activity and conformational studies of geometrically restricted tripeptide analogues of the chemoattractant HCO-Met-Leu-Phe-OMe.

Boggian M, Vertuani G, Cavicchioni G, Pecoraro R, Scatturin A, Spisani S. Boggian M, et al. Among authors: cavicchioni g. Farmaco. 1997 Jun-Jul;52(6-7):439-44. Farmaco. 1997. PMID: 9372595

4

Delta-selective opioid peptides containing a single aromatic residue in the message domain: an NMR conformational analysis.

Crescenzi O, Amodeo P, Cavicchioni G, Guerrini R, Picone D, Salvadori S, Tancredi T, Temussi PA. Crescenzi O, et al. Among authors: cavicchioni g. J Pept Sci. 1996 Sep-Oct;2(5):290-308. doi: 10.1002/psc.56. J Pept Sci. 1996. PMID: 9230457

5

Oligomeric formylpeptide activity on human neutrophils.

Cavicchioni G, Fraulini A, Falzarano S, Spisani S. Cavicchioni G, et al. Eur J Med Chem. 2009 Dec;44(12):4926-30. doi: 10.1016/j.ejmech.2009.08.010. Epub 2009 Aug 31. Eur J Med Chem. 2009. PMID: 19748709

6

New chemotactic dimeric peptides show high affinity and potency at the human formylpeptide receptor.

Spisani S, Fraulini A, Varani K, Falzarano S, Cavicchioni G. Spisani S, et al. Among authors: cavicchioni g. Eur J Pharmacol. 2007 Jul 12;567(1-2):171-6. doi: 10.1016/j.ejphar.2007.04.006. Epub 2007 Apr 14. Eur J Pharmacol. 2007. PMID: 17481605

7

A hydrophilic residue at position 2 can improve specific biological responses in fMLP-OMe analogs.

Cavicchioni G, Spisani S. Cavicchioni G, et al. J Pept Res. 2001 Sep;58(3):257-62. doi: 10.1034/j.1399-3011.2001.00917.x. J Pept Res. 2001. PMID: 11576332

8

Biological variation responses in fMLP-OMe analogs, introducing bulky protecting groups on the side-chain of hydrophilic residues at position 2.

Cavicchioni G, Turchetti M, Spisani S. Cavicchioni G, et al. J Pept Res. 2002 Oct;60(4):223-31. doi: 10.1034/j.1399-3011.2002.21019.x. J Pept Res. 2002. PMID: 12366529

9

Properties of a novel chemotactic esapeptide, an analogue of the prototypical N-formylmethionyl peptide.

Cavicchioni G, Turchetti M, Varani K, Falzarano S, Spisani S. Cavicchioni G, et al. Bioorg Chem. 2003 Aug;31(4):322-30. doi: 10.1016/s0045-2068(03)00070-1. Bioorg Chem. 2003. PMID: 12877881

10

Biological activity of for-Met-Leu-Phe-OMe analogs: relevant substitutions specifically trigger killing mechanisms in human neutrophils.

Cavicchioni G, Fraulini A, Turchetti M, Varani K, Falzarano S, Pavan B, Spisani S. Cavicchioni G, et al. Eur J Pharmacol. 2005 Apr 4;512(1):1-8. doi: 10.1016/j.ejphar.2005.02.013. Eur J Pharmacol. 2005. PMID: 15814083

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters